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Glucose-6-phosphate dehydrogenase (G6PD) mutations that result in reduced enzyme activity have been implicated
in malarial resistance and constitute one of the best examples of selection in the human genome. In the present
study, we characterize the nucleotide diversity across a 5.2-kb region of G6PD in a sample of 160 Africans and
56 non-Africans, to determine how selection has shaped patterns of DNA variation at this gene. Our global sample
of enzymatically normal B alleles and A, A5, andMed alleles with reduced enzyme activities revealsmany previously
uncharacterized silent-site polymorphisms. In comparison with the absence of amino acid divergence between human
and chimpanzee G6PD sequences, we find that the number of G6PD amino acid polymorphisms in human pop-
ulations is significantly high. Unlike many other G6PD-activity alleles with reduced activity, we find that the age
of the A variant, which is common in Africa, may not be consistent with the recent emergence of severe malaria
and therefore may have originally had a historically different adaptive function. Overall, our observations strongly
support previous genotype-phenotype association studies that proposed that balancing selection maintains G6PD
deficiencies within human populations. The present study demonstrates that nucleotide sequence analyses can reveal
signatures of both historical and recent selection in the genome and may elucidate the impact that infectious disease
has had during human evolution.
Introduction
Infectious disease has likely had a large impact on the
evolution and differentiation of human populations (e.g.,
see Cooke and Hill 2001). Therefore, characterization of
nucleotide variability in genes that play a role in resistance
or susceptibility to infectious disease will be important
for understanding how selection shapes patterns of var-
iability and linkage disequilibrium (LD) in the human
genome. Although general practice is to identify an as-
sociation between DNA variants and disease phenotypes
in infected individuals, it is also necessary to examine
patterns of genetic variation in uninfected individuals,
to determine the impact that selection has on the pop-
ulation as a whole. Natural selection can alter levels of
nucleotide variability in several ways. For example, bal-
ancing selection may maintain allelic diversity within and
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among populations, whereas directional selectionmay re-
sult in a reduction of nucleotide variability and increased
LD at targeted genes relative to that expected under a
neutral model. However, it is unclear whether either of
these selection regimes is a predominant explanation for
patterns of molecular variation in the human genome
(Przeworski et al. 2000;Wall and Przeworski 2000;Nach-
man 2001). Several studies of candidate genes connected
to disease phenotypes have identified the impact of natural
selection in human populations (Clark et al. 1998; Ste-
phens et al. 1998; Salamon et al. 1999; Fullerton et al.
2000; Nachman and Crowell 2000; Hamblin et al. 2002);
however, not all show a “signature” of selection (Harding
et al. 1997; Aquadro et al. 2001). Therefore, in continuing
to characterize the nucleotide sequence diversity for genes
related to disease resistance, we can begin to understand
how selection has influenced patterns of variability in the
human genome.
One of the most studied infectious diseases is malaria
(Greenwood and Mutabingwa 2002), which affects 500
million people each year and is a leading cause of death
in the global human population. Although epidemics are
prevalent in many areas of the world, Africa is the most
strongly affected by this disease (Miller 1994). Archae-
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ological evidence suggests that malaria has had a signif-
icant effect on humans only in the past 10,000 years,
which is consistent with the advent of agriculture, animal
domestication, and increased human populationdensities
in this geographic region (Livingstone 1971). Estimates
of genetic diversity in the mosquito vector Anopheles
gambiae (Donnelly et al. 2001) and the protozoan par-
asite Plasmodium falciparum, which causes severe ma-
laria (Anderson et al. 2000; Mu et al. 2002), are in
accordance with the predicted recent expansion of hu-
man populations and may be due to the coevolution of
these organisms. Several human genes show a strong
association with malarial resistance (Miller 1994). One
major candidate gene encodes glucose-6-phosphate
dehydrogenase (G6PD [MIM 305900]), an important
“housekeeping” enzyme in the glycolytic pathway for
glucose metabolism. G6PD also plays a critical role in
maintaining the balance of reduced nicotinamide ade-
nine dinucleotide phosphate (NADPH), a necessary co-
factor for cell detoxification. Although several enzymes
can recycle this essential cofactor, G6PD is the sole gen-
erator of NADPH in the red blood cells and alone may
prevent oxidative damage and severe anemia.
G6PD deficiency is the most common known enzy-
mopathy and is estimated to affect 400 million people
worldwide. More than 130 different G6PD variants that
lead to reduced enzyme activity have been discovered
at the DNA level (Luzzatto et al. 2001). G6PD enzyme
deficiency is associated with many clinical disorders,
such as neonatal jaundice, hemolytic anemia, and sev-
eral cardiovascular diseases (Beutler 1994). The G6PD
locus is located on the telomeric region of the long arm
of the X chromosome (at Xq28) and is flanked for 300
kb on each side by Factor VIII and the red/green color-
vision genes, which have been widely studied for their
association with hemophilia (Toole et al. 1986) and
color blindness, respectively (Nathans et al. 1986; Deeb
et al. 1992).
Although G6PD deficiency is associated with many
clinical disorders, there are three observations that sug-
gest that G6PD deficiencies are selectively maintained.
First, G6PD deficiency is strongly associated with the
distribution of malarial endemicity, and many variants
are found at rare-to-high frequencies in different pop-
ulations (Vulliamy et al. 1992). A single amino acid
replacement is responsible for the classic G6PD A/B
polymorphism. The B variant, which possesses normal
enzyme activity and dominates in frequency worldwide,
is predicted to be the ancestral state by comparison with
chimpanzee G6PD (Kay et al. 1992). The A variant,
which is due to a derived amino acid replacement in
exon 5, possesses 85% enzyme activity and is found in
sub-Saharan Africa at frequencies as high as 40% but
rarely reaches frequencies 11% outside Africa and the
Middle East (Beutler 1994; Ruwende et al. 1995).
Although many other G6PD amino acid replacements
have been discovered (Beutler 1994), there are two com-
mon variants with severely low enzyme activities. The
A deficiency is the result of an amino acid replacement
in exon 4 and is always associated with the amino acid
change that gives rise to the A allele. This deficiency has
only 12% enzyme activity and is found at frequencies as
high as 25% in sub-Saharan Africa, but it is very rare in
all other regions except the Mediterranean, where it is
found at a frequency of nearly 5% (Beutler 1994). The
Med deficiency, which is due to an amino acid replace-
ment in exon 6 on a B allele and possesses only 3%
enzyme activity, is typically found at frequencies of
2%–20% in the Mediterranean and as high as 70% in
Kurdish Jews (Beutler 1994).
The second observation that argues for an adaptive
explanation for G6PD deficiency comes from a study by
Ruwende et al. (1995), who have showed that the A
deficiency can reduce the risk of malarial infection by
46%–58% in both heterozygous females and hemizygous
males. It is likely that the oxidative stress imposed by
G6PD deficiency in the red blood cells also creates a toxic
environment for thePlasmodium parasites that causema-
laria (Vulliamy et al. 1992;Miller 1994). AlthoughG6PD
enzyme deficiency may have detrimental effects, the ben-
efit that it provides in the presence of malaria suggests
that G6PD deficiency may be maintained by balancing
selection. Ruwende et al. (1995) have found that the A
variant, which reduces enzyme activity by 15%, does not
significantly deter malarial infection. Therefore, it is pos-
sible that only a severe reduction in G6PD activity can
act as a successful inhibitor of malarial infection.
The third observation is from a study inwhichTishkoff
et al. (2001) examined seven RFLPs at the G6PD locus
and microsatellite variation in close proximity (within 18
kb downstream), to investigate the extent to which se-
lection for the A and Med variants has affected LD in
this gene region. This study estimates that the A variant
likely arose 3,840–11,760 years before present (BP) and
that the Med variant likely arose 1,600–6,640 years BP.
Because this is consistent with the estimated time for the
spread of severe malaria (Livingstone 1971), it is possible
that the A and Med variants were favored by selection
for malarial resistance. The study by Tishkoff et al.
(2001) shows that selection has had a large impact on
the frequencies of the A and Med deficiencies; how-
ever, we were also interested in what impact selection
has had on G6PD nucleotide diversity in a large and
random sample of individuals.
In the present study, we present an analysis of DNA
sequence variation across a 5.2-kb region of the G6PD
locus for both African and non-African groups, to ad-
dress several questions related to the evolutionary his-
tory of G6PD protein polymorphism. To date, all known
G6PD amino acid polymorphisms come from studies of
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Table 1
Population Diversity Estimates
Sample na Sb pc Dd he
African: 160 22 .72 .90 .85
West African: 105 18 .71 .46 .88
Cameroonf 16 8 .55 .23 .75
Sierra Leoneg 44 14 .72 .26 .79
Nigeria 22 10 .69 .11 .79
Bakola Pygmies 23 11 .71 .08 .88
East African: 32 15 .71 .73 .92
Hadza 11 9 .70 .28 .83
Maasai 10 11 .70 .17 .79
Sandawe 11 12 .76 1.04 .94
South African
Bantu-speakers 23 11 .76 .16 .78
Non-African: 56 8 .35 .46 .45
Tunisia 9 8 .65 .42 .54
Cyprus 9 3 .34 1.02 .69
Lebanon 12 3 .30 .78 .44
South American
Andean 12 3 .35 1.47 .49
Papua New Guinea 14 2 .07 1.46 .14
Global 216 23 .73 .95 .82
a Number of chromosomes.
b Number of silent-site SNPs.
c Average pairwise sequence differences per site (# 103).
d Tajima’s D statistic (all tests nonsignificant).
e Haplotype diversity for B alleles only (see the “Results” section).
f Includes the Mandara, Podoko, Uldeme, Bakaka, and Bassa groups.
g Includes the Mende, Temne, Creole, Fula, Limba, Loko, and
Madingo groups.
individuals who possess G6PD enzyme deficiency. By us-
ing a nucleotide sequence approach in randomly selected
individuals, we can determine whether there are other
amino acid replacement polymorphisms at the nucleotide
level, in addition to those that have already been dis-
covered in functional assays. We can also compare the
level of silent-site polymorphism in coding and non-
coding regions of G6PD with other human genes. Ad-
ditionally, we were interested in whether patterns of
nucleotide diversity at G6PD are consistent with bal-
ancing selection for amino acid variation, as predicted
by the observed cost and benefit associated with G6PD
deficiency (Ruwende et al. 1995).
Finally, we were interested in whether G6PD amino
acid polymorphism is consistent with selection for ma-
larial resistance. If this is the case, then we may expect
these G6PD variants to be both common and very recent
in age, as found for the A and Med variants (Tishkoff
et al. 2001). Although the A variant does not seem to
act as a significant barrier to malarial infection (Ru-
wende et al. 1995), a site-directed mutagenesis experi-
ment found that both the A and A variants are needed
to produce the 12% enzyme activity observed for the
A allele (Town et al. 1992). Therefore, a characteri-
zation of the underlying nucleotide variability associ-
ated with the A allele may reveal the effects of a yet
unknown selective pressure that is responsible for the
frequency of this common variant.
Subjects and Methods
Population Samples
Sequence variation was surveyed from DNA samples
from 216 male individuals from 13 populations (table
1). Our sub-Saharan African sample (labeled as “Afri-
can”) consists of 160 individuals from 8 different
groups. Several of these samples were from similar ethnic
groups that individually were small in sample size (often
!5); therefore, they were pooled together (see table 1).
We also sampled 56 individuals from groups outside sub-
Saharan Africa (who are hereafter referred to as “non-
African”). Finally, the same G6PD fragment was se-
quenced from four male chimpanzees (Pan troglodytes
troglodytes) for interspecific comparisons. The G6PD
locus is found on the X chromosome (at Xq28); there-
fore, the sampling of males enabled the unambiguous
determination of all polymorphic sites (i.e., no hetero-
zygous sites) and complete haplotype phase for all in-
dividuals. The present study was approved by the insti-
tutional review board at the University of Maryland. All
samples were gathered with informed consent.
PCR and Sequence Determination
All primers used in the present study are based on Gen-
Bank accession number X55448 and are available at S.
A. Tishkoff’s Web page (Tishkoff Lab at the University
of Maryland). PCR was used to amplify the 5.2-kb frag-
ment shown in figure 1. Exon 1 is not translated, and
exon 2 is separated from exons 3–13 by the 10 kb of
intron 2, which includes many Alu repeats. Although it
is possible that additional undiscovered mutations may
reside in the 210 bp of exon 2, our analysis focused on
the region that spans exons 3–13, where nearly all de-
ficiency mutations recorded to date have been discov-
ered. PCR products were prepared for sequencing by
using shrimp alkaline phosphatase and exonuclease I
(US Biochemicals). All nucleotide sequence data were
obtained using the ABI Big Dye terminator kit and the
3100 automated sequencer (Applied Biosystems), and
all variants were confirmed on both strands. Sequence
files were aligned using the Sequencher program (ver-
sion 4.0.5; Gene Codes).
Data Analysis
Samples were initially screened for the A, A, andMed
variants, as described by Tishkoff et al. (2001), and a
constructed random sample (CRS) was sequenced on the
basis of the estimated population frequencies of the dif-
ferent major alleles (Hudson et al. 1994). For example,
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Figure 1 Diagram of the G6PD locus, spanning ∼18 kb. Exons are shown as blackened boxes, and introns and noncoding regions are
shown as unblackened boxes. Intron 2 is nearly 10 kb in length. The 5.2-kb region that was sequenced for this study is shown, as well as the
location of the common A, A, and Med replacement SNPs.
the A variant has an average frequency of 20% in Africa.
Therefore, our African samples were screened for the A
variant, and we randomly sampled 32 A alleles to include
in our total of 160Africans (for a total frequency of 20%).
If certain alleles of interest are over- or underrepresented
in our sample, then this will significantly influence esti-
mates of nucleotide variability, population structure, age
of alleles, and LD at the G6PD locus. By this approach,
parameter estimates (i.e., v and m) and statistical tests for
our sample will reflect the frequencies of major G6PD
alleles in natural populations.
This data set will also enable us to make comparisons
of LD within African and non-African samples, as well
as for deficiency and normal-activity alleles. Stronger LD
may be associated with non-African samples because of
recent population expansion (Tishkoff et al. 1996, 1998,
2000; Tishkoff and Williams 2002), whereas strong LD
may be associated with deficiency alleles if selection has
recently increased their frequencies. The Rozas and Ro-
zas (1999) DnaSP program (version 3.53) was used to
compute the correlations for all pairwise comparisons
between SNPs as R2. Significant associations were iden-
tified with x2 tests by using a Bonferroni correction for
multiple comparisons (Sokal and Rohlf 1995). We also
used the four-gamete test of Hudson and Kaplan (1985)
to estimate theminimum number of recombination events
in our sample.
A locus-specific variation estimate based on the num-
ber of segregating silent sites (which will include SNPs
both at synonymous sites and in introns throughout the
study) and corrected by sample size was calculated using
Watterson’s v (1975). This estimate was compared with
p, which is an estimate based on the average number of
pairwise differences at silent sites between all alleles.
These two estimates of the parameter 3Nem (for X-linked
genes) were calculated for all populations and allele clas-
ses (e.g., B, A, and A). These two parameter estimates
are expected to be equal under a strict model of neu-
trality, which can be assessed using the test designed by
Tajima (1989). PositiveD values may be consistent with
balancing selection, whereas negative D values suggest
directional selection. We were also interested in whether
selection on amino acid variants has distorted the ge-
nealogical structure for specific allele samples. For ex-
ample, compared to the overall level of silent polymor-
phism at G6PD, does our sample of alleles bearing the
A variant contain a significantly lower level of silent
variation? Using the coalescent simulator, found inDnaSP,
that adopts the approach of Hudson et al. (1994), we
constructed 10,000 replicate trees based on the observed
v at G6PD and compared the observed levels of SNP
variation for each of the B, A, and A samples with the
simulated data sets.
The ratio of amino acid replacement:silent polymor-
phisms within humans was compared with the ratio of
replacement:silent fixed differences between humans and
chimpanzees, using Fisher’s exact test of independence
(Sokal and Rohlf 1995), as described by McDonald and
Kreitman (1991). Because polymorphism and divergence
are expected to be correlated, the ratios of these different
nucleotide-site comparisons should be equal under neu-
trality. The Hudson, Kreitman, and Aguade (HKA) test
(Hudson et al. 1987) can be applied to test whether the
level of silent-site polymorphism at G6PD is consistent
with neutrality. If a simple neutral explanation accounts
for variation at G6PD, then we may expect that silent-
site polymorphism and divergence will be the same across
loci. We tested this hypothesis by comparing G6PD with
other X-linked loci for which estimates of silent-site poly-
morphism and divergence were available.
We used the statistic FST, from Hudson et al. (1992),
as a relative measure of population differentiation, with
all estimates weighted by sample size. We also used the
Snn statistic, from Hudson (2000), to measure the amount
of genetic differentiation across subpopulations. As Snn
approaches 1, a sequence’s most closely related sequence
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Figure 2 Summary data for 5.2-kb region of G6PD for 216 individuals. All polymorphisms are shown as derived changes as compared
with the “chimp” sequence. Nucleotide positions start with the first base pair of exon 3 (the first SNP is in the second intron 135 bp before
exon 3). Coding-region SNPs are labeled as “r” and “s,” for replacement and silent sites, respectively; deletions are labeled as “d1”–“d4”; and
the row labeled as “tree” refers to the African SNPs that were used in the GENETREE analysis (fig. 5). Although haplotype H was originally
typed as an A allele, it does not have the site 177 SNP that is common to all other A alleles (see the “Results” section).
is more often found in other sampled populations than
in its own population. A permutation test shuffles the
populations and reconstructs them on the basis of their
original sample sizes. The proportion of samples with Snn
larger than or equal to the observed value is the estimated
P value.Whereas our estimate of FST is a standardmeasure
of population differentiation, the Snn statistic, using pair-
wise sequence differences, provides a method to detect
genetic differentiation among subpopulations. A Bonfer-
roni test was used to correct for multiple comparisons
(Sokal and Rohlf 1995).
Finally, we used two different analyses to examine the
evolutionary relationship of G6PD alleles. Although re-
combination can obscure the true genealogical relation-
ship among alleles, these analyses likely reflect an ac-
curate representation of the genealogical structure of our
sample, because we find evidence for only one recom-
bination event (see below). First, using MEGA (version
2.1) (Kumar et al. 2001), we constructed a simple neigh-
bor-joining tree in which chimpanzee sequence was used
as an outgroup to visualize both the population and
allelic structure at G6PD. This analysis is based only on
silent SNPs within and between humans and chimpan-
zees, thus illustrating the clustering of silent variation
and populations independently of replacement SNPs.
Second, we used the coalescent analysis outlined byGrif-
fiths and Tavare (1997) and the GENETREE program
(available at R. C. Griffiths’ Web page [Genetree Soft-
ware Version 9.0]) to estimate the time to themost recent
common ancestor (TMRCA) for our entire sample, as well
as for the B, A, and A alleles. This analysis assumes
no homoplasy in our sample; therefore, we removed
haplotype N (which accounts for only two individuals
in fig. 2) to correct for the single observed recombination
event in our sample. This method uses maximum-like-
lihood (ML) coalescent analyses to estimate the tree to-
pology under the assumptions that mutations are neutral
and that allele age, frequency, and intra-allelic variability
are correlated (Slatkin and Rannala 1997;Wuif and Don-
nelly 1999). Although selection has likely altered patterns
of DNA variation at G6PD, we can examine the ages of
alleles that would be consistent with amodel of neutrality,
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Table 2
Intra-Allelic Diversity Estimates
Sample na Sb pc Dd
Global:
Be 165 15 .55 .62
A 32 5 .20 .91
A 17 1 .03 1.15
A/A 49 6 .29 .30
African:
B 112 15 .51 .86
A 32 5 .20 .91
A 16 0 .00 …f
A/A 48 5 .27 .04
Non-Africane 53 3 .30 1.77
Chimpanzee 4 9 1.10 .79
a Number of chromosomes.
b Number of silent-site SNPs.
c Average pairwise sequence differences per site (# 103).
d Tajima’s D statistic (all tests nonsignificant).
e Includes only the normal B alleles.
f Tajima’s test cannot be performed because no silent SNPs are
found in this sample.
and we can compare this with the results from other stud-
ies that have used the same approach (Harding et al. 1997;
Harris and Hey 1999, 2001; Jaruzelska et al. 1999; Ful-
lerton et al. 2000).
Results
G6PD Nucleotide Sequence Variation
A diagram of the 5.2-kb region, on the G6PD gene,
that was surveyed in the present study is shown in figure
1. There are 1,428 bp in exons 3–13 (475 codons) and
3,772 bp of noncoding sequence (introns and a portion
of the 3′ UTR), for a total of 4,058 effectively silent sites.
This number is used to calculate all measures of nucle-
otide diversity and is equal to the sum of all sites within
exons that are silent (i.e., third-base positions) and sites
within introns except the two conserved splice sites at
the beginning and end of each intron. All SNP data are
shown in figure 2 with the haplotype-frequency sum-
mary for each of the 13 population samples.
The constructed random sample (CRS) (see the
“Subjects and Methods”section) from 160 Africans
included 112 B, 32 A, and 16 A alleles, whereas the
sample from 56 non-Africans included 1 Med, 1 A,
and 54 B alleles. A total of 32 variable sites were
discovered in the 5.2-kb region. There are four inser-
tion/deletion polymorphisms in introns (comparison
with the chimpanzee G6PD implies that all are de-
letions) and 28 SNPs at 17 intron and 11 coding sites.
Of the 11 SNPs in coding regions, 5 replacement SNPs
were found at sites 177 (ValrMet change at amino
acid residue 68, which results in the A variant), 902
(AsnrAsp change at amino acid residue 126, which
results in the A variant), 1760 (SerrPhe change at
amino acid residue 188, which results in the Med var-
iant), 3154 (LeurPro change at amino acid residue
323, which results in a second A variant), and 3922
(ArgrHis change at amino acid residue 463, which
results in the Kaiping variant). Earlier functional as-
says had labeled all alleles that possessed a specific
enzyme activity and electrophoretic profile as “A
alleles.” However, DNA analyses revealed that these
samples were not all due to the replacement SNP at
site 177. For example, a replacement SNP at site 3154
was found in our Cameroon sample; this replacement
SNP was originally labeled as “an A variant,” be-
cause it possesses similar enzyme activity to the com-
mon A variant at site 177, and is also found only
with the A variant (Beutler 1994). The amino acid
replacement that occurs at site 3922 was found in our
Cyprus sample; this variant was first labeled as “the
Kaiping deficiency” and was initially discovered in
China and Laos (Beutler et al. 1992; Chang et al. 1992).
All measures of sequence variability are summarized
in tables 1 and 2. Because insertion/deletion polymor-
phisms likely do not conform to the same expectations
as SNPs (i.e., mutation rates may differ), they are omit-
ted from all statistical analyses. On the basis of silent
sites for the overall sample of 216 individuals, our two
nucleotide-variability measures, v and p, are 0.094%
and 0.073%, respectively, which is consistent with other
polymorphism studies (Przeworski et al. 2000; Nachman
2001). Table 1 shows that all Tajima tests are nonsignif-
icant, which suggests that the polymorphism-frequency
distribution for our overall sample is consistent with that
expected under a simple model of neutrality.
Table 2 shows that the level of silent-site nucleotide
variability associated with the global sample of 165 nor-
mal B alleles ( ) is almost twice that seen forpp 0.055%
all 49 A/A alleles ( ), including 32 A andpp 0.030%
17 A alleles. Our Tajima tests show no significant skew
in the polymorphism-frequency distribution for each of
the B, A, and A allelic groups. The global sample of
17 A alleles segregates only a singleton polymorphism
(i.e., a variant that is only found once), which is found
at site 1402. Additionally, the A variant at site 177 is
the only difference between all A and A alleles. In the
examination of the variation associated with the differ-
ent allele classes, the non-African sample was omitted
from our DnaSP coalescent simulations, because it con-
tains only a single A allele. Given the number of silent
SNPs in our CRS from 160 Africans (22 silent SNPs),
our simulations find that the presence of 15 SNPs in the
sample of 112 B alleles is not unusual. However, the
association of five silent SNPs with the 32 A alleles
( ) and the complete lack of polymorphism in theP ! .01
16 A alleles (P ! .001) were both rare events in the
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Figure 3 Measurements and plots of LD and association. a,
Relationship between the LD measure as and the distance (in bp)2R
between 15 SNPs found at frequencies 13% in the African sample
from 160 individuals. Blackened circles indicate the 25 associations,
of the 105 possible, that are significant at the 0.01% level by a x2 test
and Bonferroni correction. b, Plot of the association among the 15
African SNPs for 160 individuals. Blackened boxes indicate significant
LD at the 0.01% level, and numbers denote the nucleotide positions
of SNPs in figure 2. c, Plot of LD for the 112 African B alleles. Black-
ened boxes indicate significance at the 0.01% level for 9 of the possible
36 associations, for the nine SNPs found at frequencies 13% in the
African sample.
coalescent simulations. These observations support a re-
cent ancestry for the A allele class, which is consistent
with the microsatellite and LD analyses by Tishkoff et
al. (2001). These results also suggest that the A allele
may have recently risen to intermediate frequency as
well. Finally, not one of the 23 silent SNPs is shared
among the A and B clades, and, on average, A and B
alleles differ by twice as many silent SNPs as any two
B alleles in our sample (4.3 vs. 2.0).
A total of 12 Med alleles sampled from Cyprus and
Lebanon were initially sequenced for the same 5.2-kb
region to examine the nucleotide variation associated
with sequences bearing this specific deficiency variant.
For our statistical analyses, only a single individual was
included in our non-African CRS to reflect the frequency
of the Med variant in this geographic region. Inciden-
tally, all 12 sequences were identical, which reflects a
recent ancestry of the Med variant; this recent ancestry
is also consistent with Tishkoff et al. (2001).
LD
If the frequencies of several SNPs are rare, then LD
analyses will lack the power to detect significant asso-
ciations among sites, and, consequently, this can result
in an overestimate of linkage equilibrium among SNPs.
In our analysis, we find that our sample size is sufficiently
large to detect significant LD with SNPs that have fre-
quencies 3%. Only three SNPs met this criterion in
the CRS from 56 non-Africans, and all three pairwise
comparisons among them were highly significant (each
, ). In the CRS from 160 Africans,2R 1 0.83 P ! .0001
15 SNPs had a frequency3%. Figures 3a and 3b show
the 25 comparisons, of the possible 105 pairwise com-
parisons, that are significant (each ). BecauseP ! .0001
much of this LD might result from differences between
the B and A clades, we also tested LD within each allele
class. The A alleles have only two SNPs with frequencies
13% (sites 1623 and 2319), and they are in significant
LD ( ). There are nine SNPs in the 112 AfricanP ! .0001
B alleles that are 13% in frequency, and 9 of the 36
pairwise comparisons among them exhibit significant
LD (shown in fig. 3c) ( ). We may expect thatP ! .0001
strong LD on deficiency alleles is a result of recent se-
lection for malarial resistance; however, we find that sig-
nificant LD at G6PD is also associated with African B
alleles that possess normal enzyme activity. Further ev-
idence for strong LD within our sample is provided by
the four-gamete test (Hudson and Kaplan 1985), which
reveals only one recombination event (between SNPs
2830 and 3441) in our sample.
Population Differentiation
Our estimates of silent-site nucleotide variability for
the CRS from 160 Africans are 0.095% and 0.072%
for v and p, respectively (table 1). We find that our
African sample exhibits twice as much genetic diversity
as our non-African sample ( ), and, of thepp 0.035%
28 SNPs found in our global sample, only 1 silent and
2 replacement singletons are unique to the non-African
sample. Although there is a threefold difference in sam-
ple size between our African and non-African samples,
this is accounted for in all population parameter esti-
mates (e.g., v, p, and h) and therefore cannot explain
the differences in nucleotide or haplotype diversity be-
tween the two samples.
Because our CRS is based on our a priori knowledge
of the average frequencies of the A and A variants in
African and non-African populations, it is statistically
invalid to subsequently test for differences in frequency
for the A and A variants across our population sam-
ples. We may expect that selection acting on the replace-
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Table 3
Summary Statistics of Population Structure
Sample Contrasta FST Snn
b P
All (13) .159 .190 .0001
Among Africans (8) .021 .228 .0001
Among African regions (3) .000 .472 .1710
Among all regions (4): .128 .508 .0001
West vs. East Africans .000 .626 .1320
West vs. South Africans .000 .685 .3180
West vs. non-Africans .151 .793 .0001
East vs. South Africans .000 .461 .8040
East vs. non-Africans .131 .757 .0001
South vs. non-Africans .160 .804 .0001
Among East Africans (3) .022 .418 .0840
Among West Africans (4) .030 .415 .0001
Among non-Africans (5) .107 .212 .1930
Africans vs. non-Africans (2) .127 .805 .0001
a Number of population samples in contrast is given in parentheses.
“African regions” denotes the West, East, and South African groups;
“all regions” denotes the three African groups and the non-African
sample. Only B alleles were included (see the “Results” section).
b Hudson’s (2000) Snn statistic. Significance was assessed by per-
mutation tests ( [in boldface italics]; see the “Subjects andP ! .001
Methods” section).
ment SNPs determines their geographic variation and
that silent SNPs in our sample will also show the same
pattern of geographic variation because of the strong
LD across the G6PD gene; however, we expect that the
haplotype structure composed of silent SNPs within each
of the B, A, and A classes will reflect neutral processes,
such as gene flow and drift (Berry and Kreitman 1993;
Verrelli and Eanes 2001; Hamblin et al. 2002). We were
interested in examining both the A and B allele classes
for population structure. However, the A allele class seg-
regates only two SNPs (sites 1623 and 2319) and is not
found outside our African sample; therefore, we used
only the global sample of 165 B alleles.
Table 1 shows that the African B haplotype diversity
(0.85) is almost twice that of the non-African sample
(0.45). The FST estimates in table 3 show that, although
13%–16% of the total diversity is found between the
African and non-African samples, the differences among
African populations are very small. The Hudson (2000)
Snn statistical analysis finds significant population struc-
ture between African and non-African samples indepen-
dently of the A and A variants. Although there is little
difference in genetic diversity among African groups, we
do find significant heterogeneity within the West African
sample. A further inspection of theWest African samples
shows that the Pygmy sample is genetically different
( ), which is consistent with other studies of thisP ! .01
ethnic group (Cavalli-Sforza et al. 1996) and may reflect
reduced gene flow between Pygmies and other Africans.
Although all replacement SNPs were omitted fromour
neighbor-joining analysis, figure 4 shows two distinct
clades for the A/A and B alleles. This clustering of silent
variation independently of the A and A replacement
SNPs demonstrates both the strong LD between silent
SNPs and the lack of shared variation between the A
and B clades. Figure 4 also indicates that A, A, and B
haplotypes are spread across the population samples;
therefore, it is unlikely that the lack of shared variation
between the two clades is a result of reduced gene flow.
Finally, figure 4 demonstrates the lack of haplotype di-
versity for the non-African sample and shows that this
sample is largely nested within African lineages.
Interspecific Comparisons
The first observation from our analysis of chimpan-
zee G6PD sequences is that the B variant is the ances-
tral state. In our chimpanzee sample, we discovered nine
silent SNPs (two of which were within exons) and no
replacement SNPs, in addition to an 8-bp insertion poly-
morphism and a 21-bp deletion polymorphism (both of
which were in introns). Our estimate of G6PD nucle-
otide variability from four individuals ( ) ispp 0.110%
much greater than that found in humans but is consistent
with other polymorphism studies in chimpanzees (Dei-
nard and Kidd 2000; Kaessmann et al. 2001; Ebersber-
ger et al. 2002). Our analysis of interspecific divergence
between chimpanzees and humans finds 44 and 0 fixed
differences at silent and replacement sites, respectively.
Table 4 contrasts this interspecific divergence with the
magnitude of intraspecific polymorphism found in our
human samples by using a McDonald-Kreitman test of
neutrality (McDonald and Kreitman 1991). Our global
sample shows a significant result, which is also seen
when the African and non-African samples are indepen-
dently tested. Because the A allele contributes two re-
placement SNPs and is found only once in our non-
African sample, the inclusion of this single allele alone
may result in a significant test. However, if we remove
the A allele from our non-African sample, then our
McDonald-Kreitman test is still significant with three
silent and two replacement SNPs from the remaining 55
individuals ( ).P ! .01
In general, our estimates of silent-site variation within
humans (p p 0.073%) and silent-site divergence from
chimpanzees (1.1%) are both consistent with other genes
(see Przeworski et al. 2000; Nachman 2001). UsingHKA
tests, we contrasted G6PD with other X-linked loci in
table 5. It is difficult to compare theG6PD polymorphism
and divergence for our non-African sample with other
loci, since other studies often include very different non-
African populations. In addition, because we find signif-
icant genetic differentiation between ourAfrican and non-
African samples, we cannot combine all individuals from
these two geographic regions to statistically test for dif-
ferences in silent variation between G6PD and other loci
(e.g., see Begun and Aquadro 1993). Table 5 shows that
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Figure 4 Neighbor-joining tree, based on only silent substitutions among 216 individuals and rooted with chimpanzee G6PD sequence.
Each haplotype is represented only once for each time it is found in a different population. Scale indicates one substitution. Non-African
haplotypes are shown in boldface italics. The A and A haplotypes differ by only a single replacement SNP; therefore, except for the single
Tunisian A allele that possesses a silent SNP, there is no distinct A haplotype clade. CA p Cameroon; SL p Sierra Leone; NA p Nigeria;
PY p Bakola Pygmies; HZ p Hadza; MS p Maasai; SW p Sandawe; BS p South African Bantu-speakers; TU p Tunisia; CY p Cyprus;
LB p Lebanon; AM p South American Andean; PNG p Papua New Guinea.
our HKA tests for X-linked loci typed in African samples
are nonsignificant, thus indicating that neither an unusual
level of silent-site polymorphism within humans nor si-
lent-site divergence with chimpanzees can explain our sig-
nificant McDonald-Kreitman tests. It is apparent that the
number of human G6PD replacement SNPs is significant-
ly greater than we would expect from a neutral model of
evolution.
Estimating the Ages of G6PD Variants
We were primarily interested in estimating the TMRCA
for the B, A, and A allele classes; therefore, we include
only the African sample in our GENETREE analysis
of the age of G6PD SNPs for two reasons. First, it is
apparent from the present study, as well as others (e.g.,
Tishkoff and Williams 2002), that non-Africans rep-
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Table 4
McDonald-Kreitman Tests of Neutrality
Samplea Silent Replacement Fisher’s Exact Test
Africans ( ):np 160
Polymorphic 22 3 P ! .05
Fixed 44 0
Non-Africans ( ):np 56
Polymorphic 8 4 P ! .001
Fixed 44 0
Global ( ):np 216
Polymorphic 23 5 P ! .01
Fixed 44 0
a Numbers of polymorphisms and fixed differences found at both
silent and replacement (i.e., those that change the amino acid) sites
are contrasted with a Fisher’s exact test of independence (see2# 2
the “Subjects and Methods” section).
resent a subset of the genetic diversity found within
African populations, which suggests that the common
ancestor for our non-African sample is rooted within
Africa. Second, our non-African sample can contribute
very little to our estimate of the age of the A variant,
given that this variant was found only once in our non-
African sample. For this analysis, we used the observed
number of silent differences between humans and chim-
panzees as our locus-specific estimate of the neutral
mutation rate. If we take the average of the two within-
species nucleotide-variation estimates from p and sub-
tract this from the amount of divergence between spe-
cies, then our estimate of the net sequence divergence
is 43 fixed differences. Under the assumptions of a hu-
man-chimpanzee divergence time of ∼5 million years
(Myr) BP (Horai et al. 1992) and of ∼20 years per
generation, the estimated neutral mutation rate per
generation (m) along each species’ lineage is .59 # 10
We used the GENETREEML estimate of the parameter
v and our m estimate from above to calculate the ef-
fective population size (Ne) from the relationship vp
(X linked) as 19,800 for our African sample.3N me
Figure 5 shows the results for all 25 African SNPs, and
table 6 summarizes age estimates of specific interest.
Our coalescent analysis enables us to estimate the
ages of SNPs (i.e., the A and A variants), as well as
the coalescent time back to a common ancestor for spe-
cific haplotype groups (i.e., the TMRCA for each of the B
and A clades). We have estimated the TMRCA of our Af-
rican sample at 620 thousand years (kyr) BP (95% CI
480–760 kyr), which is similar to estimates from other
gene genealogies for African samples (Harding et al.
1997; Fullerton et al. 2000). Our estimate of the TMRCA
for our 112 African B alleles ( kyr BP) is not426 254
significantly different from the TMRCA for the entire sam-
ple. We also find that the coalescent time for the A clade
( kyr BP, which is the point at which our316 244
sampled A alleles coalescence to a common ancestor)
overlaps with that of the B clade. Because the TMRCAs
for each of the A and B clades are not significantly dif-
ferent, it is likely that the divergence within these two
clades occurred during the same relative time period.
This time period also includes our estimate for the origin
of the A variant ( kyr BP). Using the same420 120
methodology, we find, for our non-African B sample, an
ancestry that is more recent ( kyr BP) than241 189
that for our African B sample. This is likely explained
by a recent founding and a smaller effective population
size of non-African populations, which is consistentwith
other studies using the same approach (Harding et al.
1997; Harris and Hey 1999, 2001). Although our es-
timates for the ages of the A ( kyr BP) and45 20
Med ( kyr BP) variants are slightly higher than10 25
that found by Tishkoff et al. (2001), they represent a
very recent origin for these deficiencies relative to that
found for all other G6PD alleles.
Discussion
In screening large samples from human populations, in-
itial studies had as their primary goal the identification
of newG6PD deficiencies based on enzymatic properties.
Although such screening was necessary for understanding
the functional implications of mutations in this gene re-
gion, especially in relationship to malarial endemicity, we
were interested in characterizing the amino acid variation
in a random sample of individuals. Therefore, in an effort
to better understand how selection has shaped G6PD
diversity globally, we have sampled 56 non-African and
160 African individuals, together representing the largest
study, to date, of nuclear DNA diversity for sub-Saharan
Africans. By using this sequence-based approach, we
have identified amino acid changes at the DNA level in
a large sample, and we have compared these changes
with findings from functional assays. The present study
finds five replacement SNPs, which have all been doc-
umented in previous studies and are associated with re-
duced enzyme activity compared with normal B alleles.
The absence of any amino acid variation other than that
responsible for the common deficiencies implies that
there is very little hiddenG6PD amino acid replacement
polymorphism at high frequency.
The Signature of Balancing Selection
Compared with other loci, at G6PD, we see a typical
level of silent-site fixation (1.1%) between chimpanzees
and humans, which implies a normal level of fixation of
neutral mutations at this locus. If much of the human
G6PD protein variation is simply neutral, then we may
expect that, like the silent-site variation, some of this neu-
tral amino acid variation increases in frequency and con-
tributes to fixation between humans and chimpanzees.
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Table 5
HKA Tests of G6PD versus Other X-Linked Loci for African Samples
Locus na Sitesb Sc Dd HKA x2 Reference
PDAH1 16 3,788 24 44 1.250 Harris and Hey (1999)
ZFX 113 1,089 7 13 .048 Jaruzelska et al. (1999)
Xq13.3 23 10,163 24 95 .254 Kaessmann et al. (2001)
Dmd (int44) 10 3,000 15 27 1.700 Nachman and Crowell (2000)
FIX 16 3,731 6 37 .750 Harris and Hey (2001)
FY (regVIII) 16 1,440 6 54 2.064 Hamblin et al. (2002)
a Number of chromosomes sampled.
b Number of silent sites at sampled locus.
c Number of silent-site SNPs.
d Divergence measured as number of silent-site differences between chimpanzees andhumans.
Table 6
Summary of GENETREE Estimates
Sample na vML
b Ne
c TMRCA
d 95% CI
African 158 5.35 19,800 620 480–760
B lineage 110 3.40 13,000 426 172–680
A lineage 32 1.73 6,400 316 72–560
Non-Africane 55 1.00 3,700 241 52–430
a Number of chromosomes sampled after predicted recombinants
were omitted (see the “Subjects and Methods” section).
b ML estimate of nucleotide variability per locus from the GENE-
TREE analysis.
c Effective population size derived from vML and /lo-
5mp 9# 10
cus/generation (see the “Results” section).
d Mean age estimate (in kyr) derived from Ne, with a generation
time of 20 years (see the “Results” section).
e The single A allele is omitted (see the “Results” section).
However, the absence of amino acid fixation suggests that
there has been strong historical purifying selection against
G6PD amino acid polymorphism and that this has been
operating in both species. Given the lack of amino acid
fixation, the significant excess of G6PD amino acid poly-
morphism that we find segregating within human pop-
ulations is all the more surprising.
A significant excess of amino acid polymorphism is
typically explained by either balancing selection or
slightly deleterious selection. If amino acid polymor-
phisms are completely deleterious, then they are re-
moved by selection almost immediately. However, if
purifying selection against deleterious amino acid var-
iants within species is sufficiently weak because amino
acid variation is “slightly” deleterious, then these
amino acid variants may remain polymorphic at low
frequencies, but eventually selection will keep them
from high frequencies and fixation (Ohta 1992). Al-
though this theory is in accordance with the posses-
sion, by several genes, of rare amino acid polymor-
phisms (Nachman et al. 1996; Nielsen and Weinreich
1999; Harding et al. 2000; Fay et al. 2001; Smirnova
et al. 2001), other genes do not show this pattern
(Clark et al. 1998; Salamon et al. 1999; Fullerton et
al. 2000; Koda et al. 2001). Amino acid polymor-
phisms at G6PD are not all rare in frequency, and, in
fact, many are found to be as high as 40%–70% in
frequency in specific populations. For example, in ad-
dition to the common A and Med variants in African
and Mediterranean regions, respectively, the Union
variant, from Melanesia (Ganczakowski et al. 1995),
and the Orissa variant, from India (Kaeda et al. 1995),
are common to their respective geographic regions.
Although this does not imply that all amino acid poly-
morphism is adaptive, both the high-frequency and
positive-fitness attributes of enzyme deficiencies (Ru-
wende et al. 1995) convincingly reject a slightly del-
eterious selection model at G6PD.
Although the association between enzyme deficiencies
and geographic regions of malarial prevalence largely sug-
gested balancing selection, it was unclear how this might
impact variation both within and between species at the
nucleotide level. Our comparison of human and chim-
panzee G6PD nucleotide sequences implies that there
has been no protein change for this enzyme possibly for
the past 5 Myr. Therefore, the abundant G6PD amino
acid polymorphism is likely the result of a relatively recent
change in selective pressures in human populations. Det-
rimental amino acid polymorphisms that would be selec-
tively removed in the effectively larger population of Af-
rica may be neutral and can accumulate in the relatively
smaller effective population of non-Africans. This argu-
ment has been used to explain the presence, in non-Af-
rican populations, of rare melanocortin-1 receptor amino
acid polymorphisms that are absent in African popula-
tions (Harding et al. 2000). In contrast, our McDonald-
Kreitman analysis finds a significant excess of G6PD
amino acid polymorphism in both African and non-Af-
rican populations. If this amino acid polymorphism in
non-African populations simply reflected a recent increase
in neutral variation, then we might also expect a relative
increase in silent-site variation; however, we actually find
an eightfold reduction of silent-site variation in non-Af-
ricans as compared with Africans. In addition, our con-
trasts of G6PD with other X-linked loci by using HKA
tests indicate that silent polymorphism in African popu-
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Figure 5 GENETREE results for 158 African individuals (haplotype N is omitted; see the “Subjects and Methods” section). The number
and letter codes for the SNPs and haplotypes, respectively, are found in figure 2. All replacement SNPs are shown in boxes. SNPs 2 and 7
designate the common A and A variants, respectively. Although haplotype H was originally labeled as “an A allele” on the basis of functional
analyses, it does not have the common SNP 2 (see the “Results” section). The order of SNPs in time is arbitrary when they are found on the
same branch (e.g., SNPs 1, 7, and 16), and ages for all variants are mean estimates.
lations is not unusually high (which was also recently
found by Saunders et al. [in press]). This suggests that
G6PD amino acid polymorphism in both African and
non-African populations is maintained by selection.
Global Patterns of Population Differentiation
Our analysis of silent variation at G6PD in figure 4,
showing that global populations likely had an ancestral
root within Africa, and our coalescent analysis, showing
a large difference in Ne between Africans and non-Af-
ricans, are both consistent with other studies (Harding
et al. 1997; Harris and Hey 1999, 2001; Jaruzelska et
al. 1999; Fullerton et al. 2000). This difference in genetic
diversity between these two geographic regions is often
explained by the colonization of non-African populations
by an effectively smaller number of individuals emerging
out of Africa (Tishkoff andWilliams 2002). Although our
estimates of Ne for both African and non-African popu-
lations may differ compared with other studies, different
genes are expected to show contrasting patterns of genetic
diversity because Ne likely varies across genomic regions
as a result of selection, drift, different recombinationrates,
and the stochastic variance that is associated with pop-
ulation sampling (Hey 1997; Hey and Harris 1999).
Although there are several documented cases in which
population-specific G6PD variants have been found in
other geographic regions (see Beutler 1994), including
our finding of the Kaiping variant (of Southeast Asia)
in Cyprus, this observation likely reflects limited gene
flow across non-African populations. We might expect
that gene flow plays a large role in the distribution of
adaptive variation to different populations and that re-
stricted gene flow would hinder the evolution of human
traits, such as resistance to disease. However, our anal-
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ysis suggests that selection does not necessarily favor
specific G6PD amino acid variants per se but that en-
zyme deficiency in general is adaptive. This is seen from
the convergence of populations toward a similar en-
zyme-deficiency phenotype that is the result of unique
mutations at the G6PD locus. Therefore, in spite of lim-
ited gene flow, recent balancing selection can effectively
maintain both normal and deficiency G6PD phenotypes
in natural populations, because of repeated amino acid
mutation. This is an example of convergent evolution
due to a common selective pressure across populations
and is analogous to the pattern of variation observed
for b-globin hemopathologies, such as sickle cell anemia
and thalassemia.
A general observation from other genetic diversity anal-
yses of mtDNA and nuclear genes, as well as microsatel-
lites, implies that African populations may have been
historically subdivided (Tishkoff and Williams 2002),
yet we find very little genetic differentiation among our
African samples. However, the extent to which subdi-
vision will be detected will depend on the relative time
of population divergence, gene flow, the underlying level
of genetic variability, and, most important, the differ-
ential strength of selection across the genome. Therefore,
studies with highly variable markers (i.e., microsatellite
haplotypes) may be more informative for the detection
of population structure in Africa (Tishkoff et al. 1996,
1998, 2000; Jorde et al. 1997; Tishkoff and Williams
2002). Nonetheless, the observation that A alleles sam-
pled from geographically diverse African groups possess
the same SNP and microsatellite haplotype backgrounds
indicates that both gene flow and selection have main-
tained this enzyme deficiency across Africa (Tishkoff et
al. 2001).
The Ages of G6PD Amino Acid Variants
We were interested in how our coalescent analyses of
nucleotide variation would compare with the approach
of Tishkoff et al. (2001) in using LD and microsatellite
variation. The analyses of Tishkoff et al. (2001) estimated
the ages of the A and Med variants to be 3,840–11,760
and 1,600–6,640 years BP, respectively. The absence of
fixed silent SNPs between A and A alleles and the
significantly low level of silent variation associated with
the sample of A alleles (as found by the DnaSP coa-
lescent simulations) support a recent origin and rapid
increase in frequency for the A variant, which has an
estimated age of kyr BP from our GENETREE45 20
analysis. The lack of nucleotide sequence variation as-
sociated with our sample of 12 Med alleles and the es-
timated age of the Med variant as kyr BP from10 25
our GENETREE analysis are also consistent with a re-
cent ancestry for this deficiency. In contrast to our study
of DNA sequence variation, Tishkoff et al. (2001) used
faster-evolving microsatellite markers to more accurately
resolve the ages of the A and Med variants. Tishkoff
et al. (2001) also considered selection models to fit the
pattern of variation associated with the A and Med
alleles, whereas our standard coalescent model assumes
strict neutrality. Therefore, although deficiency alleles
that are high in frequency may appear to be older in
origin, their frequencies may simply be a result of recent
selection. The relative lack of nucleotide variation as-
sociated with the A and Med alleles indicates that this
may be the case. Our significant McDonald-Kreitman
tests also suggest that the general pattern of G6PDamino
acid polymorphism is consistent with relatively recent
balancing selection.
Although the A variant does not appear to be recently
derived, the coalescent time for the entire A clade is con-
sistent with the estimated time of divergence of African
and non-African populations within the past 100,000
years (Tishkoff and Williams 2002). It is possible that
the A variant is old in origin but that the divergence of
the A clade may have been recent andmay have occurred
sometime after the colonization of non-African groups.
Several derived SNPs are associated with the A clade;
however, our Tajima tests find no skew toward rare SNPs
that may be expected if selection has recently increased
the frequency of the A variant. Simulations show that
Tajima’s test does possess the statistical power to detect
distortions in the polymorphism-frequency spectrum
(Braverman et al. 1995); however, this test may be weak
if selection has been relatively recent (Simonsen et al.
1995). Therefore, if selection on the A and A alleles
has been recent, then our Tajima tests are likely nonsig-
nificant because there has been little time for SNPs to
accumulate on these haplotype backgrounds. In con-
trast, our DnaSP coalescent simulations find that both
the A and A clades segregate significantly lower levels
of SNP variation given the overall level of variation at
G6PD. If the A variant was historically lower in fre-
quency and has recently become more common because
of selection, then this may have provided little oppor-
tunity for recombination between A and B alleles and
may explain the association of several derived SNPs (i.e.,
sites 135, 1623, 2319, and 2766) with A alleles.
Although several G6PD variantsmay be under selection
for resistance to malaria, our analysis of the A variant
suggests that this SNP predates the estimated age at which
severe malaria has likely had a major impact in humans.
It is possible that there was a period of time whenmalaria
was less severe; therefore, selection for G6PD deficiencies
with low, but not severely reduced, enzyme activity main-
tained the A variant at low frequencies. With the expan-
sion of human populations and the rapid growth of ag-
riculture, selection for more-extreme G6PD deficiencies
(i.e., the A andMed variants) may have become necessary
as severe malaria became highly prevalent. As with the
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CCR5-D32 polymorphism, which is not recent in origin
but is strongly associated with resistance to HIV infection
(Martin et al. 1998), it is also possible that the A variant
had been historically maintained by an unknown selective
pressure in African populations. This possibility may re-
quire additional studies of the A variant, to identify an
association with malarial resistance or with another func-
tion altogether. Finally, Saunders et al. (in press) find sig-
nificant LD between the A allele and genes as far as 550
kb away. Therefore, future analyses of haplotype varia-
tion at other genes in close proximity may elucidate the
effect that selection on the A and A variants has had
on LD in this region.
Depending on the surrounding environment, G6PD
variants can be beneficial or detrimental. We may ex-
pect that selection for malarial resistance initially drives
up the frequencies of new deficiencies but also that
balancing selection for normal enzyme activity even-
tually maintains these deficiency alleles at intermediate
frequencies. Therefore, it is unlikely that these amino
acid polymorphisms will become fixed. Instead, some
form of spatially or temporally varying selective pres-
sure may maintain A, A, and Med deficiency alleles,
in addition to normal B alleles, across geographic
regions. Because selection for the A and Med variants
has been recent, analyses of microsatellite haplotypes
were informative for the demonstration of the recent
ancestry of these alleles (Tishkoff et al. 2001). In con-
trast, because SNP mutation rates are lower, they are
more informative for the investigation of historical
events that occur deep in the genealogical history of
genes—such as the fixation of silent and replacement
SNPs between humans and chimpanzees.
Because of the historical association between Plasmo-
dium and mammals, many Plasmodium species have
adapted to specific primate hosts. However, unlike hu-
mans that are infected by P. falciparum,many nonhuman
primate species are infected by other Plasmodium species
that are associated with less-severe forms of malaria (Ol-
lomo et al. 1997). In comparison with humanG6PD, our
chimpanzee sample has a higher level of silent variation
yet segregates no amino acid variation. Although this sam-
ple is small, it may be the case that G6PD amino acid
variation is not adaptive in chimpanzees, because malaria
may be rare and less detrimental in this species. Future
analyses of G6PD nucleotide sequence variation in non-
human primates may reveal how selection impacts closely
related species that are exposed to varying degrees ofPlas-
modium infection.
In accordance with other studies, we have revealed that
selection for disease resistance can be associated with a
complex pattern of nucleotide variability (Clark et al.
1998; Fullerton et al. 2000; Kidd et al. 2000; Nachman
and Crowell 2000; Hamblin et al. 2002; Tishkoff and
Williams 2002). To determine how selection has im-
pacted different genomic regions, one may need to em-
ploy a combination of genetic markers with different
mutation rates (i.e., microsatellites and SNPs). In addi-
tion, it is imperative to examine patterns of coevolution
among Plasmodium, Anopheles, and human genomes in
the development of new vaccines and disease-prevention
tactics (Hoffman et al. 2002; Miller et al. 2002). Finally,
it has been proposed that common diseases—such as
hypertension, diabetes, and obesity—are results of his-
torical selection for mutations beneficial in an ancestral
environment but detrimental in modern environments
(i.e., “thrifty” genotypes). Therefore, characterization of
selection in the human genome will be important for the
identification of loci that are associated with common
diseases. Analysis of genetic variation at G6PD, a locus
thought to be under strong selection, indicates that cer-
tain tests of selection may lack the power to reject neu-
trality. However, our comparisons of intraspecific vari-
ation with interspecific divergence, as well as analyses
of microsatellite variation and LD, reflect the signature
of recent balancing selection at G6PD.
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